Developer docs
API playgroundTry for free, no card

Search company profiles

Proprio

Full company profile

uuid00003th

Namestring
Proprio
Legal namestring
Proprio
Company typeenum
Private
Founded yearint
2016
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersSeattle, United States
HQ citystring
Seattle
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
surgical navigation systems, AI surgical guidance, computer vision surgery, intraoperative imaging, spine surgery technology
Industry5 codes
PRIMARYHLAHADAF
Surgical Robotics & Computer-Assisted Surgery Platforms
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAG
Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHAEAL
Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLACAGAJ
Surgical, Perioperative & ERAS Pathway Tools
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Decision Support (CDS) & Care Pathway Tools
SECONDARYHLAHABAG
Interventional Radiology & Image-Guided Therapy Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
NAICS code1 code
  • Computer Systems Design and Related Services54151
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Surgical Navigation and AI Surgical Guidance
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Paradigm Platform Licensing
TypeSubscription Recurring
Description

B2B licensing model for AI-powered surgical guidance platform to hospitals and surgical centers. Platform provides real-time 3D visualization, intraoperative measurements, and data capture capabilities.

propriovision.com
2Surgical Technology Platform
TypeHardware Sales
Description

Medical device/software platform revenue model combining hardware sensors with AI software capabilities for surgical guidance and data collection.

propriovision.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Enterprise hospital licensing - Quote-based pricing
ModelSubscriptionBilling cadenceAnnual
Notes

No specific pricing tiers publicly available. Sales conducted through direct enterprise engagement with hospital systems and surgical centers.

prnewswire.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1Paradigm
Description

AI-powered surgical guidance platform providing real-time 3D visualization, intraoperative measurement, and data-driven insights for spine surgery.

propriovision.com
+2 more records
Core offering1 text field

Proprio Paradigm is an AI-powered surgical guidance platform that combines proprietary computer vision, light-field imaging, and artificial intelligence to provide surgeons with continuous 3D visualization and real-time intraoperative measurement of anatomy during surgery. The platform enables progress-to-plan tracking against pre-operative imaging without interrupting procedures for X-rays or CT scans, replacing traditional radiation-based surgical navigation. It is sold as an enterprise solution combining hardware sensor arrays with AI software and cloud infrastructure to hospitals, academic medical centers, and ambulatory surgery centers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 10X reduction in radiation exposure for patients and OR staff
+3 more records
Product overview1 text field

Proprio offers a single unified platform called Proprio Paradigm, supplemented by modular add-on capabilities and supporting services. Paradigm is the core AI-powered surgical guidance platform that combines proprietary computer vision, light-field imaging, and artificial intelligence to deliver real-time 3D visualization, intraoperative measurement, and automated data capture during surgery. Within the Paradigm platform, discrete capabilities have been launched and cleared by the FDA individually — including the core light-field navigation system, an intraoperative measurement module, and the Picasso feature for trace-based optical registration. Proprio also provides a Virtual Lab experience for hands-on evaluation and is building a comprehensive surgical video dataset to fuel AI-powered research and analytics. The company operates its cloud infrastructure on AWS and was recently recognized with the Fast Company World Changing Ideas Award and a Silver International Design Excellence Award.

Product and service1 record
1Proprio Paradigm
CategoryAI Surgical Guidance Platform
Description

AI-powered surgical guidance platform combining proprietary computer vision, light-field imaging, and artificial intelligence to provide surgeons with continuous 3D visualization, precise intraoperative alignment measurement, and automated data capture during surgery. Enables progress-to-plan tracking against pre-operative plans in real time without interrupting procedures for X-rays or CT scans. Sold to hospitals, academic medical centers, and ambulatory surgery centers as an enterprise solution combining hardware sensor arrays with AI software.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
1Harms Study Group
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-11-12
Description

Research collaboration to integrate intraoperative data with Harms Study Group's global outcomes registry for spine surgery research. Collaboration involves real-time data collection during surgeries to enhance data quality, support new research, and improve surgical outcomes through AI and computer vision. Project focuses on advancing pediatric and adolescent spinal deformity treatment.

prnewswire.com
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-07-29
Description

Proprio joined the Amazon Web Services (AWS) Partner Network (APN), a global community of AWS Partners. Partnership enables Proprio to leverage AWS scalable infrastructure and AI capabilities to train and deploy AI models, integrate with healthcare data systems, and deliver robust security and compliance for hospitals and research networks worldwide.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-01-13
Description

Strategic distribution partnership with LifeHealthcare (subsidiary of EBOS Group Limited) to serve as distribution partner for Proprio Paradigm in Australia and New Zealand. Additional phases will expand distribution throughout Southeast Asia. LifeHealthcare will leverage its extensive track record and deep relationships in the region to bring AI surgical guidance to hospitals and surgeons.

4Dave Demski (Individual Advisor)
Strategic tierKeyTypeStrategic or Co-development Partner
Description

Former CEO of Globus Medical joined Proprio as Senior Strategic Advisor. Demski brings two decades of experience building one of the most successful platform companies in medtech, with pivotal role in Globus' early robotics investment. Provides strategic guidance as Proprio enters commercial stage.

propriovision.com
Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Medtronic's StealthStation surgical navigation and Mazor robotic spine surgery platforms are the most established incumbents in spine surgical guidance. Direct overlap with Proprio's Paradigm platform in spinal alignment, navigation, and intraoperative measurement use cases.

TypeDirect peer
Description

Globus Medical's ExcelsiusGPS robotic navigation platform competes directly with Proprio in spine surgery, and former CEO Dave Demski's move to Proprio underscores the head-to-head competitive overlap in AI-guided spine procedures.

TypeBroad incumbent
Description

Stryker's Mako robotic surgery platform and broad surgical instruments portfolio represent a broader incumbent in computer-assisted surgery; serves many of the same hospital systems Proprio targets, especially for spine and orthopedics.

TypeDirect peer
Description

Brainlab offers surgical navigation and image-guided therapy platforms used in spine and neurosurgery. Overlaps directly with Proprio's value proposition of computer-vision-based intraoperative guidance and measurement.

TypeDirect peer
Description

NuVasive (now part of Globus Medical) historically competed in spine surgical enabling technology, including Pulse platform for surgical planning and navigation — comparable customer base of spine surgeons and hospitals.

TypeBroad incumbent
Description

Smith+Nephew's CORI handheld robotic surgery system targets orthopedic surgical guidance, addressing similar AI/navigation use cases for orthopedic surgeons and hospital ORs as Proprio's spine-focused platform.

TypeEmerging player
Description

Augmedics developed the xvision Spine System, an AR-based surgical guidance headset for spine procedures — a direct emerging competitor using augmented reality rather than light-field imaging for intraoperative spine guidance.

TypeBroad incumbent
Description

Philips' Azurion interventional platform and broader image-guided therapy franchise overlap with Proprio's intraoperative imaging and AI guidance capabilities, particularly in complex hospital procedure suites.

TypeBroad incumbent
Description

Johnson & Johnson's DePuy Synthes spine portfolio and emerging surgical robotics programs (MONARCH, Ottava) represent a deep-pockets incumbent moving into AI-enabled surgical guidance with overlapping hospital customer relationships.

TypeBroad incumbent
Description

Siemens Healthineers' Corindus vascular robotics and broader digital health portfolio represent an adjacent surgical robotics incumbent with imaging AI capabilities that could expand into Proprio's domain.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles16 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors14 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Proprio

Surgical Navigation and AI Surgical Guidancepropriovision.com

Proprio firmographics

Firmographics
Name
Proprio
Legal name
Proprio
Website
https://propriovision.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
1,001–5,000 employees
Ownership category
akta.pro rank

Proprio industry classification

Industry
Product category
Surgical Navigation and AI Surgical Guidance
NAICS
Computer Systems Design and Related Services (54151)
SIC
Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro industry
PRIMARYHLAHADAF
Surgical Robotics & Computer-Assisted Surgery Platforms
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAG
Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHAEAL
Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLACAGAJ
Surgical, Perioperative & ERAS Pathway Tools
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Decision Support (CDS) & Care Pathway Tools
SECONDARYHLAHABAG
Interventional Radiology & Image-Guided Therapy Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment

Keywords

  • Surgical navigation systems
  • AI surgical guidance
  • Computer vision surgery
  • Intraoperative imaging
  • Spine surgery technology

Where Proprio is headquartered

Location

Headquarters

HQ city
Seattle
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Proprio business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Paradigm Platform Licensing: B2B licensing model for AI-powered surgical guidance platform to hospitals and surgical centers. Platform provides real-time 3D visualization, intraoperative measurements, and data capture capabilities.
  2. Surgical Technology Platform: Medical device/software platform revenue model combining hardware sensors with AI software capabilities for surgical guidance and data collection.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise hospital licensing - Quote-based pricing

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Proprio product offering

Product offering

Core offering

Proprio Paradigm is an AI-powered surgical guidance platform that combines proprietary computer vision, light-field imaging, and artificial intelligence to provide surgeons with continuous 3D visualization and real-time intraoperative measurement of anatomy during surgery. The platform enables progress-to-plan tracking against pre-operative imaging without interrupting procedures for X-rays or CT scans, replacing traditional radiation-based surgical navigation. It is sold as an enterprise solution combining hardware sensor arrays with AI software and cloud infrastructure to hospitals, academic medical centers, and ambulatory surgery centers.

Product overview

Proprio offers a single unified platform called Proprio Paradigm, supplemented by modular add-on capabilities and supporting services. Paradigm is the core AI-powered surgical guidance platform that combines proprietary computer vision, light-field imaging, and artificial intelligence to deliver real-time 3D visualization, intraoperative measurement, and automated data capture during surgery. Within the Paradigm platform, discrete capabilities have been launched and cleared by the FDA individually — including the core light-field navigation system, an intraoperative measurement module, and the Picasso feature for trace-based optical registration. Proprio also provides a Virtual Lab experience for hands-on evaluation and is building a comprehensive surgical video dataset to fuel AI-powered research and analytics. The company operates its cloud infrastructure on AWS and was recently recognized with the Fast Company World Changing Ideas Award and a Silver International Design Excellence Award.

Differentiator

Problem solved

Functional benefit

Brands

  • Paradigm: AI-powered surgical guidance platform providing real-time 3D visualization, intraoperative measurement, and data-driven insights for spine surgery.
  • Paradigm™
  • Picasso

Products and services

  • Proprio Paradigm AI-powered surgical guidance platform combining proprietary computer vision, light-field imaging, and artificial intelligence to provide surgeons with continuous 3D visualization, precise intraoperative alignment measurement, and automated data capture during surgery. Enables progress-to-plan tracking against pre-operative plans in real time without interrupting procedures for X-rays or CT scans. Sold to hospitals, academic medical centers, and ambulatory surgery centers as an enterprise solution combining hardware sensor arrays with AI software.

Quantifiable outcome

  • 10X reduction in radiation exposure for patients and OR staff
  • +3 more outcomes

Companies that use Proprio

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Proprio technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature5 records

Proprio partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and key.

  • Harms Study GroupcoreStrategic or Co-development Partner · 12 November 2025Research collaboration to integrate intraoperative data with Harms Study Group's global outcomes registry for spine surgery research. Collaboration involves real-time data collection during surgeries to enhance data quality, support new research, and improve surgical outcomes through AI and computer vision. Project focuses on advancing pediatric and adolescent spinal deformity treatment.
  • Amazon Web Services (AWS)coreTechnology or Integration · 29 July 2025Proprio joined the Amazon Web Services (AWS) Partner Network (APN), a global community of AWS Partners. Partnership enables Proprio to leverage AWS scalable infrastructure and AI capabilities to train and deploy AI models, integrate with healthcare data systems, and deliver robust security and compliance for hospitals and research networks worldwide.
  • LifeHealthcarecoreChannel Partner/ Reseller/ Distributor · 13 January 2025Strategic distribution partnership with LifeHealthcare (subsidiary of EBOS Group Limited) to serve as distribution partner for Proprio Paradigm in Australia and New Zealand. Additional phases will expand distribution throughout Southeast Asia. LifeHealthcare will leverage its extensive track record and deep relationships in the region to bring AI surgical guidance to hospitals and surgeons.
  • Dave Demski (Individual Advisor)keyStrategic or Co-development PartnerFormer CEO of Globus Medical joined Proprio as Senior Strategic Advisor. Demski brings two decades of experience building one of the most successful platform companies in medtech, with pivotal role in Globus' early robotics investment. Provides strategic guidance as Proprio enters commercial stage.

Scale indicators8 records

Recent moves8 records

Expansion highlights5 records

Proprio competitors and assessment

Company assessment

Direct peers

  • Medtronic: Medtronic's StealthStation surgical navigation and Mazor robotic spine surgery platforms are the most established incumbents in spine surgical guidance. Direct overlap with Proprio's Paradigm platform in spinal alignment, navigation, and intraoperative measurement use cases.
  • Globus Medical: Globus Medical's ExcelsiusGPS robotic navigation platform competes directly with Proprio in spine surgery, and former CEO Dave Demski's move to Proprio underscores the head-to-head competitive overlap in AI-guided spine procedures.
  • Brainlab: Brainlab offers surgical navigation and image-guided therapy platforms used in spine and neurosurgery. Overlaps directly with Proprio's value proposition of computer-vision-based intraoperative guidance and measurement.
  • NuVasive: NuVasive (now part of Globus Medical) historically competed in spine surgical enabling technology, including Pulse platform for surgical planning and navigation — comparable customer base of spine surgeons and hospitals.

Broad incumbents

  • Stryker: Stryker's Mako robotic surgery platform and broad surgical instruments portfolio represent a broader incumbent in computer-assisted surgery; serves many of the same hospital systems Proprio targets, especially for spine and orthopedics.
  • Smith+Nephew: Smith+Nephew's CORI handheld robotic surgery system targets orthopedic surgical guidance, addressing similar AI/navigation use cases for orthopedic surgeons and hospital ORs as Proprio's spine-focused platform.
  • Philips (Image-Guided Therapy): Philips' Azurion interventional platform and broader image-guided therapy franchise overlap with Proprio's intraoperative imaging and AI guidance capabilities, particularly in complex hospital procedure suites.
  • Johnson & Johnson (DePuy Synthes / MONARCH / Ottava): Johnson & Johnson's DePuy Synthes spine portfolio and emerging surgical robotics programs (MONARCH, Ottava) represent a deep-pockets incumbent moving into AI-enabled surgical guidance with overlapping hospital customer relationships.
  • Siemens Healthineers (Corindus): Siemens Healthineers' Corindus vascular robotics and broader digital health portfolio represent an adjacent surgical robotics incumbent with imaging AI capabilities that could expand into Proprio's domain.

Emerging players

  • Augmedics: Augmedics developed the xvision Spine System, an AR-based surgical guidance headset for spine procedures — a direct emerging competitor using augmented reality rather than light-field imaging for intraoperative spine guidance.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Proprio social profiles

Digital presence

Proprio financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Proprio leadership team

Management profile

Number of profiles

Profiles16 records

Proprio funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors14 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Proprio M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Proprio

What does Proprio do?

Proprio Paradigm is an AI-powered surgical guidance platform that combines proprietary computer vision, light-field imaging, and artificial intelligence to provide surgeons with continuous 3D visualization and real-time intraoperative measurement of anatomy during surgery. The platform enables progress-to-plan tracking against pre-operative imaging without interrupting procedures for X-rays or CT scans, replacing traditional radiation-based surgical navigation. It is sold as an enterprise solution combining hardware sensor arrays with AI software and cloud infrastructure to hospitals, academic medical centers, and ambulatory surgery centers.

Is Proprio a public or private company?

Proprio is a private company. It is classified as venture growth investor backed and is currently operating.

When was Proprio founded?

Proprio was founded in 2016. It employs 1,001 to 5,000 people.

Where is Proprio based?

Proprio is headquartered in Seattle, United States, in the North America region.

How does Proprio make money?

Two revenue lines are on record. Paradigm Platform Licensing is the primary driver. The others are surgical Technology Platform.

Who are Proprio's main competitors?

Direct peers on record are Medtronic, Globus Medical, Brainlab and NuVasive. Broad incumbents are Stryker, Smith+Nephew, Philips (Image-Guided Therapy), Johnson & Johnson (DePuy Synthes / MONARCH / Ottava) and Siemens Healthineers (Corindus). Augmedics is listed as an emerging player.

Does Proprio have an API?

No public API is recorded for Proprio.

What industry is Proprio in?

Proprio's product category is Surgical Navigation and AI Surgical Guidance. Its primary akta.pro industry code is HLAHADAF, Surgical Robotics & Computer-Assisted Surgery Platforms, with a secondary code of HLAHADAG, Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT). Its NAICS code is 54151 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
SkyquesttStrategy, Technology & Market IntelligenceThe article examines how 2025 became an inflection point for the global medical device industry, with AI shifting from experimental to embedded clinical functionality, wearable therapies gaining mainstream adoption, and regulatory frameworks enabling faster commercialization. Key developments included Medtronic's FDA-approved adaptive deep brain stimulation technology, Osteoboost's FDA-cleared wearable for low bone density, Sebela Women's Health's novel copper IUD, and Proprio's AI-powered surgical guidance platform, while South Korea launched a $622.1 million government initiative to boost next-gen medical technology innovation. The article signals that 2026 capital is expected to concentrate on AI-native devices, connected surgical platforms, neuromodulation, and clinically validated wearable therapies with clear reimbursement pathways.GlobeNewswireExplosive Growth in AI for Orthopedic Surgery Market: $0.87 Billion by 2030 at 27.2% CAGRResearchAndMarkets.com announced the addition of the "AI in Orthopedic Surgery Market Report 2026" to its offerings, projecting the market to grow from $0.26 billion in 2025 to $0.87 billion by 2030 at a 27.2% CAGR, driven by increased orthopedic surgeries, medical imaging innovations, and adoption of minimally invasive techniques. Key developments include Proprio's FDA-cleared Paradigm platform launch in April 2025 and moveUP.care's acquisition of Deep Structure.ai in March 2025 to integrate AI technologies into orthopedic practices. North America led the market in 2025, while tariffs on advanced surgical technologies are affecting costs in Asia-Pacific and Europe while stimulating domestic innovation.Market ScoopAI in Spine Surgery MarketThe global AI in Spine Surgery Market is projected to grow from US$ 1.2 billion in 2025 to US$ 6.6 billion by 2035, representing a compound annual growth rate of 18.5% during the forecast period. North America dominated the market with a 52.6% revenue share in 2025, while Asia Pacific is expected to record the highest growth rate going forward. Multiple FDA 510(k) clearances for AI-powered surgical guidance platforms were granted in 2025, including approvals for Proprio Paradigm, Surgical Theater SyncAR Spine, Carlsmed Aprevo, and Augmedics X2 headset, with Medtronic receiving clearance for its Stealth AXiS system in February 2026.SkyquesttMedical Device Innovation in 2025: Redefining the Frontiers of Clinical TechnologyA 2025 industry analysis found the medical device sector reached an inflection point as AI moved from experimental pilots to clinically embedded functionality, wearables gained mainstream regulatory approval, and regulatory frameworks accelerated commercialization without compromising safety. Notable product launches included Medtronic's FDA-approved BrainSense adaptive deep brain stimulation system, Osteoboost Health's FDA-cleared wearable for low bone density, Sebela Women's Health's copper IUD MIUDELLA, and Proprio's AI-powered Paradigm surgical guidance platform. Government support also accelerated, with South Korea announcing a USD 622.1 million initiative in November 2025 for AI diagnostics, medical robotics, and next-generation implants.LinkedInLinkedInProprio announced that it received its 4th FDA clearance for its Paradigm platform, adding a new feature called Picasso that enhances real-time 3D spinal measurements during surgery. The advancements aim to improve intraoperative assessment accuracy and align with evolving standards of care through precise data use.ThespinemarketgroupProprio’s Fourth FDA Clearance Highlights Growing Shift to 3D Measurement in Spine CareProprio, a Seattle-based surgical technology company, has received its fourth FDA clearance for the "Picasso" feature within its Paradigm AI platform, enabling trace-based optical registration for intraoperative spinal alignment measurement. The Picasso feature expands the platform's radiation-free, surgeon-controlled workflow for verifying and refining spinal alignment across a broader range of spine procedures without requiring CBCT spins or technician-led processes. The company, backed by hundreds of spine, neuro, and orthopedic surgeons contributing to its AI models, positions this milestone as part of a broader shift from traditional 2D assessment to measurement-driven 3D surgical workflows.PR NewswireProprio's Fourth FDA Clearance Highlights Growing Shift to 3D Measurement in Spine CareProprio, a Seattle-based surgical technology company, announced that the FDA has granted clearance for its Picasso feature, the fourth FDA-cleared capability within the Paradigm AI platform. The Picasso feature expands radiation-free, surgeon-controlled registration workflows that enable real-time three-dimensional intraoperative spinal alignment measurements, addressing limitations of traditional two-dimensional assessment methods. The clearance reflects accelerated progress toward more precise, measurement-driven surgical workflows and expands the company's offering for surgeons seeking alternatives to radiation-dependent navigation systems.PropriovisionProprio’s Fourth FDA Clearance Highlights Growing Shift to 3D Measurement in Surgical CareProprio announced that the U.S. Food and Drug Administration has granted clearance for its Picasso feature, the fourth FDA-cleared capability within its Paradigm AI platform, enabling radiation-free, trace-based optical registration for intraoperative spinal alignment measurements during spine procedures. The Picasso clearance expands the platform's surgeon-controlled workflow by allowing surgeons to verify and refine registration optically without requiring CBCT scans or technician-led processes. The company, led by CEO Gabriel Jones, stated that the milestone reflects growing demand for measurement-driven surgical workflows as an alternative to traditional radiation-dependent navigation systems.SkyquesttStrategy, Technology & Market IntelligenceThe global medical device industry reached a significant inflection point in 2025, driven by the integration of artificial intelligence and the regulatory approval of advanced wearable and smart therapeutic devices. Key companies including Medtronic, Osteoboost Health Inc., Sebela Women's Health Inc., and Proprio secured FDA approvals for innovations such as adaptive deep brain stimulation, bone density wearables, copper IUDs, and AI surgical guidance platforms. Concurrently, the South Korean government launched a $622.1 million initiative to accelerate innovation in AI diagnostics and medical robotics.PropriovisionAnnouncing the Proprio - Harms Study Group Research CollaborativeProprio, a medical technology company, announced a research collaboration with the Harms Study Group, a global network of 30 leading hospitals studying spine surgery outcomes, to integrate AI and real-time intraoperative data capture with HSG's longitudinal outcomes registry. The partnership aims to create continuous data streams connecting pre-, intra-, and postoperative surgical phases to improve training, reduce variability, and advance toward precision medicine in spine surgery. The collaboration positions participating hospitals to accelerate learning curves for surgeons while preserving surgical decision-making artistry.